Jill Schafer

2.0k total citations · 1 hit paper
18 papers, 1.4k citations indexed

About

Jill Schafer is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Neurology. According to data from OpenAlex, Jill Schafer has authored 18 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cardiology and Cardiovascular Medicine, 5 papers in Surgery and 3 papers in Neurology. Recurrent topics in Jill Schafer's work include Heart Rate Variability and Autonomic Control (8 papers), Cardiac pacing and defibrillation studies (6 papers) and Cardiac Arrhythmias and Treatments (4 papers). Jill Schafer is often cited by papers focused on Heart Rate Variability and Autonomic Control (8 papers), Cardiac pacing and defibrillation studies (6 papers) and Cardiac Arrhythmias and Treatments (4 papers). Jill Schafer collaborates with scholars based in United States, Germany and France. Jill Schafer's co-authors include Mitra K. Nadim, John D. Bisognano, George L. Bakris, Elyse Foster, Uday Kumar, Abraham A. Kroon, Peter W. de Leeuw, Luis A. Sánchez, Eric G. Lovett and Domenic A. Sica and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and European Heart Journal.

In The Last Decade

Jill Schafer

17 papers receiving 1.3k citations

Hit Papers

Baroreflex Activation Therapy Lowers Blood Pressure in Pa... 2011 2026 2016 2021 2011 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jill Schafer United States 10 1.3k 264 167 121 96 18 1.4k
Siegfried Eckert Germany 14 807 0.6× 280 1.1× 88 0.5× 113 0.9× 70 0.7× 50 954
Martin A. Rossing United States 9 762 0.6× 208 0.8× 122 0.7× 58 0.5× 57 0.6× 10 810
Amy E. Burchell United Kingdom 16 765 0.6× 130 0.5× 59 0.4× 54 0.4× 41 0.4× 35 1.0k
Masato Morinari Japan 12 1.2k 0.9× 341 1.3× 30 0.2× 181 1.5× 171 1.8× 17 1.5k
Jesper Fleischer Denmark 21 450 0.3× 273 1.0× 51 0.3× 354 2.9× 25 0.3× 51 1.1k
Yoko Hoshide Japan 9 1.3k 1.0× 418 1.6× 30 0.2× 119 1.0× 164 1.7× 9 1.5k
Gregory J. Hasking Australia 9 1.4k 1.1× 244 0.9× 41 0.2× 172 1.4× 69 0.7× 12 1.8k
Adam W. Cates United States 15 610 0.5× 110 0.4× 73 0.4× 51 0.4× 54 0.6× 18 690
Yuji Umeda Japan 8 1.1k 0.8× 341 1.3× 27 0.2× 124 1.0× 151 1.6× 9 1.3k
T N Jacobsen United States 11 1.1k 0.9× 290 1.1× 29 0.2× 161 1.3× 79 0.8× 13 1.5k

Countries citing papers authored by Jill Schafer

Since Specialization
Citations

This map shows the geographic impact of Jill Schafer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jill Schafer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jill Schafer more than expected).

Fields of papers citing papers by Jill Schafer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jill Schafer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jill Schafer. The network helps show where Jill Schafer may publish in the future.

Co-authorship network of co-authors of Jill Schafer

This figure shows the co-authorship network connecting the top 25 collaborators of Jill Schafer. A scholar is included among the top collaborators of Jill Schafer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jill Schafer. Jill Schafer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Schafer, Jill, et al.. (2024). Management, health, and veterinary care of donkeys in Switzerland: A cross-sectional study. Schweizer Archiv für Tierheilkunde. 166(12). 633–646. 1 indexed citations
2.
Halbach, Marcel, William T. Abraham, Christian Butter, et al.. (2018). Baroreflex activation therapy for the treatment of heart failure with reduced ejection fraction in patients with and without coronary artery disease. International Journal of Cardiology. 266. 187–192. 24 indexed citations
3.
Wachter, Rolf, William T. Abraham, JoAnn Lindenfeld, et al.. (2017). P1475Positive effects of baroreflex activation therapy in heart failure with reduced ejection fraction are independent of baseline blood pressure. European Heart Journal. 38(suppl_1). 2 indexed citations
4.
Wachter, Rolf, Marcel Halbach, George L. Bakris, et al.. (2016). An exploratory propensity score matched comparison of second-generation and first-generation baroreflex activation therapy systems. Journal of the American Society of Hypertension. 11(2). 81–91. 16 indexed citations
5.
Weaver, Fred A., William T. Abraham, William C. Little, et al.. (2016). Surgical Experience and Long-term Results of Baroreflex Activation Therapy for Heart Failure With Reduced Ejection Fraction. Seminars in Thoracic and Cardiovascular Surgery. 28(2). 320–328. 26 indexed citations
6.
Zile, Michael R., William T. Abraham, Fred A. Weaver, et al.. (2015). Baroreflex Activation Therapy for the Treatment of Heart Failure with a Reduced Ejection Fraction: Safety and Efficacy in Patients with and without Cardiac Resynchronization Therapy. European Journal of Heart Failure. 17(10). 1066–1074. 67 indexed citations
7.
Abraham, William T., Michael R. Zile, Fred A. Weaver, et al.. (2015). Baroreflex Activation Therapy for the Treatment of Heart Failure With a Reduced Ejection Fraction. JACC Heart Failure. 3(6). 487–496. 195 indexed citations
8.
Bakris, George L., Mitra K. Nadim, Hermann Haller, et al.. (2012). Baroreflex Activation Therapy provides durable benefit in patients with resistant hypertension: results of long-term follow-up in the Rheos Pivotal Trial. Journal of the American Society of Hypertension. 6(2). 152–158. 171 indexed citations
9.
Bisognano, John D., George L. Bakris, Mitra K. Nadim, et al.. (2012). Reply. Journal of the American College of Cardiology. 59(5). 541–542.
10.
Brandt, Mathias C., Rolf Wachter, Joachim Beige, et al.. (2012). MINIMALLY-INVASIVE SYSTEM FOR BAROREFLEX ACTIVATION THERAPY CHRONICALLY REDUCES BLOOD PRESSURE: INITIAL RESULTS FROM THE BAROSTIM NEO TRIAL. Journal of the American College of Cardiology. 59(13). E1784–E1784. 1 indexed citations
11.
Bisognano, John D., George L. Bakris, Mitra K. Nadim, et al.. (2011). Baroreflex Activation Therapy Lowers Blood Pressure in Patients With Resistant Hypertension. Journal of the American College of Cardiology. 58(7). 765–773. 411 indexed citations breakdown →
14.
Rao, Rajni K., et al.. (2007). Reduced Ventricular Volumes and Improved Systolic Function With Cardiac Resynchronization Therapy. Circulation. 115(16). 2136–2144. 155 indexed citations
15.
Schafer, Jill, et al.. (2006). SDANN as a Predictor of Heart Failure Hospitalizations in Cardiac Resynchronization Therapy Patients. Journal of Cardiac Failure. 12(6). S112–S113. 2 indexed citations
16.
Marcus, Gregory M., Emily Rose, Esperanza Viloria, et al.. (2005). Septal to Posterior Wall Motion Delay Fails to Predict Reverse Remodeling or Clinical Improvement in Patients Undergoing Cardiac Resynchronization Therapy. Journal of the American College of Cardiology. 46(12). 2208–2214. 94 indexed citations
17.
Saxon, Leslie A., et al.. (2004). 1059-19 Effect of cardiac resynchronization therapy in patients with right bundle branch block. Journal of the American College of Cardiology. 43(5). A14–A14. 1 indexed citations
18.
Saxon, Leslie A., Teresa De Marco, Jill Schafer, et al.. (2002). Effects of Long-Term Biventricular Stimulation for Resynchronization on Echocardiographic Measures of Remodeling. Circulation. 105(11). 1304–1310. 211 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026